Publication | Closed Access

Sustained response with gemcitabine plus Nab-paclitaxel after folfirinox failure in metastatic pancreatic cancer: Report of an effective new strategy

Pancreatic CancerGastrointestinal OncologyMedicinePharmacologyPharmacotherapyMetastatic Pancreatic CancerCancer TreatmentOncologyRadiation OncologyEffective New StrategyFolfirinox Failure